Treatment with anticoagulants in cerebral events (TRACE)

Thrombosis and Haemostasis

Volumn 91, Issue 4, 2004, Pages 690-693

  Woessner, Ralph ^a   Grauer, Markus ^b   Bianchi, Oliver ^c   Mueller, Martin ^d   Moersdorf, Stefan ^d   Berlit, Peter ^e   Goertler, Michael ^f   Grotemeyer, Karl Heinz ^g   Sliwka, Ulrich ^h   Stoll, Martin ^a   Treib, Johannes ^a  

^a Westpfalz Klinikum GmbH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c Shg Kliniken Volklingen   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g KLINIKUM SAARBRÜCKEN   (Germany)

^h Department of Neurology   (Germany)

Author keywords

Anticoagulants; Heparin; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 11144353827     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-11-0680     Document Type: Article

References (7)

1. Treib J, Grauer MT, Woessner R, et al. Treatment of stroke on an intensive stroke unit: A novel concept. Intensive Care Med 2000; 26: 1598-1611.
2. Estol CJ, Swanson RA. Intravenous heparin for acute stroke: What can we learn from the megatrials? Neurology 2000; 54: 1542-6.
3. Berge E, Abdelnoor M, Nakstad PH, et al. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355: 1205-10.
4. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. JAMA 1998; 279: 1265-72.
5. Diener HC, Ringelstein EB, von Kummer R, et al. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators. Stroke 2001; 32: 22-9.
6. Bath PMW, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial. Lancet 2001; 358: 702-10.
7. Babaikain VL, Spencer M, Ackerstaff GA, et al.. Basic identification criteria of Doppler microembolic signals. Stroke 1995; 26: 1123.